#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Neurofibroma Marfan's syndrome Chordoma Keratosis follicular Erythema multiforme Ovarian cancer stage III Epilepsy with myoclonic-atonic seizures Adenocarcinoma gastric Small cell lung cancer Non-Hodgkin's lymphoma unspecified histology indolent Small cell lung cancer recurrent Adenocarcinoma pancreas Von Willebrand's disease Prader-Willi syndrome Methylmalonic acidaemia More trials…
Learn about Rare Diseases

Factor IX deficiency – Life with Disease Mucopolysaccharidosis Burkitt’s lymphoma – Life with Disease Mitochondrial myopathy Rhabdomyosarcoma recurrent Systemic mastocytosis – Basic Information Acquired haemophilia – Trials in Disease Mitochondrial myopathy – Basic Information KBG syndrome Medulloblastoma recurrent More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

METHYLPHENIDATE Lonvoguran SGT-003 Levomethadone Hydrochloride Spironolactone Ibutamoren Mesilate Thalidomide Aripiprazole HSP-CAR30 Macrogol 4000 Cobamamide MALIC ACID Temozolomide 68Ganota-Anti-Her2 Vhh1 ATIRMOCICLIB Tryptophan Satoreotide Tetraxetan DESMOPRESSIN ACETATE Flutemetamol (18F) Vosilasarm More therapies…

Learn about Your Condition

Neuroendocrine tumour Upper limb fracture Bone sarcoma Tetanus Rheumatic disorder Vulvovaginal dryness Major depression Lichen planus Liver disorder Chordoma Acute hepatic failure Renal failure Eructation Haemorrhage prophylaxis Hypertonic bladder More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Hormone receptor negative HER2 positive breast cancer

Exercise Program Study for Early Breast Cancer Patients Taking Aromatase Inhibitors With or Without CDK4/6 Inhibitors to Improve Quality of Life

Recruiting

3 1 1 1
Investigated Drugs:
Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor negative HER2 positive breast cancer
- Hormone receptor positive breast cancer
Investigated Drugs:
+5
Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Fluoroestradiol F-18

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hormone receptor negative HER2 positive breast cancer

Exercise Program Study for Early Breast Cancer Patients Taking Aromatase Inhibitors With or Without CDK4/6 Inhibitors to Improve Quality of Life

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies